Home LiteratureArticle Details
PMID: 1519662 Published · ppublish English Journal Article

In situ hybridization and immunohistochemistry of p53 tumor suppressor gene in human esophageal carcinoma.

The American journal of pathology ·Vol. 141 ·No. 3 ·1992-09-00 ·Pages 545-50

Sasano H, Goukon Y, Nishihira T, Nagura H

Abstract

We have studied expression of p53, a tumor suppressor gene, by using both immunohistochemistry and in situ hybridization in 20 cases of squamous cell carcinoma of the esophagus. Immunohistochemical analysis was performed by using monoclonal antibody pAb1801. Immunoreactive p53 was observed in the nuclei of the tumor cells in 17 cases. We used 35S-labeled anti-sense single-stranded synthetic oligonucleotide probe ON102, which hybridized with DNA sequence near the 5' end of p53, for in situ hybridization. In all the cases of invasive squamous cell carcinoma studied, no significant accumulation of p53 hybridization signals was observed in carcinoma cells. This result indicates that overexpression of p53 observed by immunohistochemical staining is not due to an increase in the steady-state level of p53 mRNA in frank carcinoma cells. In six cases of morphologically normal esophageal mucosa distant from carcinoma, accumulation of hybridization signals was observed in basal and parabasal cells of the mucosa. The mucosa of these cases was negative for p53 immunoreactivity except for one case showing sporadic positivity. Accumulation of hybridization signals was observed in foci of squamous dysplasia not associated with invasion in three cases.

MeSH Terms
Carcinoma, Squamous Cell/genetics Esophageal Neoplasms/genetics Genes, Tumor Suppressor Genes, p53 Humans Immunohistochemistry Nucleic Acid Hybridization RNA, Messenger/metabolism
Chemicals
RNA, Messenger
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Sasano H
Department of Pathology and Surgery, Tohoku University School of Medicine, Sendai, Japan.
Goukon Y
Nishihira T
Nagura H
References (22)
22 references, click to expand
  1. Modulation of p53 gene expression and cytokeratin 18 in retinoid-mediated invasion suppressed lung carcinoma cells.
    Anticancer Res. 1990 Sep-Oct;10(5A):1335-9 PMID: 1700664
  2. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma.
    Cancer Res. 1991 Oct 15;51(20):5482-6 PMID: 1680552
  3. p53 gene mutations in Barrett's epithelium and esophageal cancer.
    Cancer Res. 1991 Aug 15;51(16):4495-9 PMID: 1868473
  4. Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens.
    Cancer Res. 1991 Nov 15;51(22):6185-9 PMID: 1933877
  5. Increased expression of mutant forms of p53 oncogene in primary lung cancer.
    Lancet. 1990 Mar 24;335(8691):675-9 PMID: 1969059
  6. Overexpression and mutation of p53 in epithelial ovarian cancer.
    Cancer Res. 1991 Jun 1;51(11):2979-84 PMID: 2032235
  7. Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.
    Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4976-80 PMID: 2052580
  8. Genetic basis for p53 overexpression in human breast cancer.
    Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5006-10 PMID: 2052583
  9. Co-localization of EGF transcripts and peptides by combined immunohistochemistry and in situ hybridization.
    J Histochem Cytochem. 1990 Dec;38(12):1853-7 PMID: 2254649
  10. Frequent mutation of the p53 gene in human esophageal cancer.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):9958-61 PMID: 2263646
  11. Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression.
    Eur J Biochem. 1986 Sep 15;159(3):529-34 PMID: 2428616
  12. Mutations in the p53 gene occur in diverse human tumour types.
    Nature. 1989 Dec 7;342(6250):705-8 PMID: 2531845
  13. p53: a frequent target for genetic abnormalities in lung cancer.
    Science. 1989 Oct 27;246(4929):491-4 PMID: 2554494
  14. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.
    Mol Cell Biol. 1988 Feb;8(2):531-9 PMID: 2832726
  15. Differential localization of mRNAs of collagen types I and II in chick fibroblasts, chondrocytes, and corneal cells by in situ hybridization using cDNA probes.
    J Cell Biol. 1986 Jun;102(6):2302-9 PMID: 3011812
  16. p53 cellular tumor antigen: analysis of mRNA levels in normal adult tissues, embryos, and tumors.
    Mol Cell Biol. 1985 Oct;5(10):2851-5 PMID: 3915536
  17. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies.
    Mol Cell Biol. 1984 Feb;4(2):276-81 PMID: 6366518
  18. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells.
    Nature. 1984 Mar 8-14;308(5955):199-201 PMID: 6366574
  19. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.
    Nature. 1984 Dec 13-19;312(5995):649-51 PMID: 6390217
  20. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors.
    Oncogene. 1992 Feb;7(2):339-46 PMID: 1312696
  21. Primary pigmented nodular adrenocortical disease (PPNAD): immunohistochemical and in situ hybridization analysis of steroidogenic enzymes in eight cases.
    Mod Pathol. 1992 Jan;5(1):23-9 PMID: 1542635
  22. p53 expression in colorectal tumors.
    Am J Pathol. 1991 Apr;138(4):807-13 PMID: 1707233
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1992-09-00
Pages
545-50
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1886688
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com